biguanides has been researched along with Animal Mammary Carcinoma in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Excerpt | Relevance | Reference |
---|---|---|
"We show here that breast tumors engage the ShcA pathway to increase their metabolism." | 1.48 | Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer. ( Ahn, R; Avizonis, DZ; Chénard, V; Gravel, SP; Hudson, J; Im, YK; McGuirk, S; Najyb, O; Pawson, T; Pollak, M; Sabourin, V; St-Pierre, J; Topisirovic, I; Ursini-Siegel, J, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Im, YK | 1 |
Najyb, O | 1 |
Gravel, SP | 1 |
McGuirk, S | 1 |
Ahn, R | 1 |
Avizonis, DZ | 1 |
Chénard, V | 1 |
Sabourin, V | 1 |
Hudson, J | 1 |
Pawson, T | 1 |
Topisirovic, I | 1 |
Pollak, M | 1 |
St-Pierre, J | 1 |
Ursini-Siegel, J | 1 |
1 other study available for biguanides and Animal Mammary Carcinoma
Article | Year |
---|---|
Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.
Topics: Animals; Biguanides; Breast Neoplasms; Disease Models, Animal; Female; Humans; Mammary Neoplasms, An | 2018 |